| 000 | 01725 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516080325.0 | ||
| 264 | 0 | _c20121126 | |
| 008 | 201211s 0 0 chi d | ||
| 022 | _a0253-3766 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Yan | |
| 245 | 0 | 0 |
_a[HER-2 expression in advanced gastric cancer and its correlation with clinical features, outcome and prognosis]. _h[electronic resource] |
| 260 |
_bZhonghua zhong liu za zhi [Chinese journal of oncology] _cSep 2011 |
||
| 300 |
_a671-5 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCapecitabine |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aEsophagogastric Junction _xpathology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aStomach _xpathology |
| 650 | 0 | 4 |
_aStomach Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aXu, Jian-ming | |
| 700 | 1 | _aLiu, Jian-zhi | |
| 700 | 1 | _aLin, Li | |
| 700 | 1 | _aGe, Fei-jiao | |
| 700 | 1 | _aLi, Shan-shan | |
| 700 | 1 | _aLiu, Lie-jun | |
| 700 | 1 | _aZhao, Chuan-hua | |
| 773 | 0 |
_tZhonghua zhong liu za zhi [Chinese journal of oncology] _gvol. 33 _gno. 9 _gp. 671-5 |
|
| 999 |
_c21550489 _d21550489 |
||